Xtant Medical Holdings Company Profile (NASDAQ:XTNT)

Analyst Ratings

Consensus Ratings for Xtant Medical Holdings (NASDAQ:XTNT) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Xtant Medical Holdings (NASDAQ:XTNT)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Xtant Medical Holdings (NASDAQ:XTNT)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Xtant Medical Holdings (NASDAQ:XTNT)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Xtant Medical Holdings (NASDAQ:XTNT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Xtant Medical Holdings (NASDAQ:XTNT)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Xtant Medical Holdings (NASDAQ:XTNT)
DateHeadline
07/20/16 03:00 PMXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclos -
07/19/16 03:44 PMXtant Medical Holdings, Inc. to Report Second Quarter 2016 Financial Results on August 1, 2016 - [GlobeNewswire] - BELGRADE, Mont., July 19, 2016-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results ...
06/17/16 07:58 AMXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to -
06/16/16 04:33 PMXtant™ Medical Announces Changes to Its Executive Management and Board of Directors - [GlobeNewswire] - BELGRADE, Mont., June 16, 2016-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced the appointment of Paul Buckman, Eric Timko, ...
05/18/16 10:42 AMXtant Medical : to Present at Investor Conferences - (GlobeNewswire) - Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), formerly Bacterin International Holdings, Inc., a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced that its ...
05/17/16 05:59 AMXtant Medical to Present at Investor Conferences - [GlobeNewswire] - BELGRADE, Mont., May 17, 2016-- Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., a leader in the development, manufacturing and marketing of orthopedic products for domestic ...
05/13/16 05:59 AMXtant Medical Sets Annual Meeting and Record Dates - [GlobeNewswire] - BELGRADE, Mont., May 13, 2016-- Xtant Medical Holdings, Inc., a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, has established a record ...
05/12/16 01:35 PMXtant™ Medical Announces the FDA Clearance for the Posterior Cervical Screw Indication on Certex® Spinal Fixation System - [GlobeNewswire] - BELGRADE, Mont., May 12, 2016-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced FDA clearance for the posterior cervical ...
05/11/16 03:30 PMXTANT MEDICAL HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report -
05/09/16 10:34 AMXtant Medical Holdings' (XTNT) CEO Daniel Goldberger on Q1 2016 Results - Earnings Call Transcript - Thank you. You may begin. Thank you, Donna. Good morning and thank you for joining us today for the Xtant Medical Holdings, Inc. first quarter 2016 results conference call. With me on the call today is Dan Goldberger, Xtant’s Chief Executive Officer.
05/04/16 03:02 PMXtant™ Medical Reports First Quarter 2016 Results - [GlobeNewswire] - See footnote about the use of pro forma financial information. Core recurring revenue increased 6.8% to $20.5 million compared to core pro forma recurring revenue of $19.2 million in first quarter 2015 ...
05/04/16 06:07 AMQ1 2016 Xtant Medical Holdings Inc Earnings Release - After Market Close -
04/27/16 01:47 PMXtant Medical Holdings, Inc. to Report First Quarter 2016 Financial Results on May 4, 2016 - [GlobeNewswire] - BELGRADE, Mont., April 27, 2016-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results ...
04/26/16 05:59 AMXtant Medical Announces Montana Department of Commerce Grant Awards - [GlobeNewswire] - BELGRADE, Mont., April 26, 2016-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced the awarding of two grants from the Montana ...
04/20/16 10:21 AMEarnings Reported After The Bell Apr. 19 - Xtant Medical Holdings, Inc. (XTNT) Q1 revenue is expected to be in the range of $20.9 million to $21.1 million. Analysts expect the company to report revenues of $22.14 million for the period. Full-year 2016 revenue to be in the range of $94 million to $ ...
04/20/16 10:21 AMXtant Medical receives FDA clearance for laminoplasty fixation system - Xtant Medical Holdings Inc. announced its subsidiary, X-spine Systems, has received FDA clearance for the Xspan Laminoplasty Fixation System. According to a press release from the company, the Xspan system is indicated for use in the lower cervical and ...
04/19/16 04:50 PMXtant Medical Pre-Announces First Quarter 2016 Revenue - [GlobeNewswire] - Core recurring revenue to increase 7% to 8% over first quarter 2015 The Company reiterates full-year 2016 revenue guidance of $94 million to $99 million and EBITDA guidance of $4.3 million to $6.3 million. ...
04/19/16 05:10 AMXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin -
04/12/16 04:56 PMEdited Transcript of XTNT earnings conference call or presentation 16-Mar-16 2:00pm GMT -
04/12/16 03:00 AMFIRE1 Closes Series B Financing, Announces New CEO - [Marketwired] - Foundry Innovation & Research 1, Ltd. today announced it has closed its Series B financing, appointed Conor Hanley as President and CEO, and added other new senior leaders to its team including John Britton, ...
04/04/16 09:37 AMXTANT MEDICAL : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) - 03/15 Xtant™ Medical Reports Record $22.3 Million Revenue and 14.1% Growth fo.. 03/08 Xtant Medical Holdings, Inc. to Report Fourth Quarter 2015 Financial Results .. 03/04 XTANT MEDICAL: Receives CE Mark for Its Aranax Cervical Plating System and Irix..
04/04/16 05:03 AMXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and -
04/01/16 09:42 AMActive Stocks Taking a Beating – LNN, XTNT, PATK, LIFE, MOV, PRGS, NPBC, ENDP - Xtant Medical Holdings Inc (XTNT) traded at $2.47 – 0.23 (8.52 percent). The company is -14.14 percent in the last four weeks, -11.79 percent year to date, and -36.34 percent during the past four quarters. Patrick Industries Inc. (PATK) traded at $44.76 ...
03/30/16 09:28 AMXtant Medical Announces FDA Clearance of the Xspan(TM) Laminoplasty Fixation System - About Xtant Medical Holdings Xtant Medical Holdings, Inc. (NYSE MKT:XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic ...
03/30/16 09:28 AMFDA clears Xtant Medical's new laminoplasty system; shares up 16% premarket - Thinly traded nano cap Xtant Medical Holdings (NYSEMKT:XTNT) is up 16% premarket, albeit on turnover of only 2,200 shares, in response to its announcement that wholly owned subsidiary X-spine Systems has received FDA clearance of its Xspan Laminoplasty ...
03/30/16 06:30 AMXtant Medical Announces FDA Clearance of the Xspan™ Laminoplasty Fixation System - [GlobeNewswire] - BELGRADE, Mont., March 30, 2016-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine ...
03/26/16 09:44 AMXtant Medical : Announces Distribution Agreement with Vivex Biomedical Bringing OsteoVive, a Cellular Allograft, to Market - (GlobeNewswire) - Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative medicine products and medical devices, is expanding its biologics portfolio through a distribution relationship with Vivex Biomedical, Inc., a leading ...
03/24/16 09:07 AMXtant Medical Announces Distribution Agreement with Vivex Biomedical Bringing OsteoVive™, a Cellular Allograft, to Market - [at noodls] - BELGRADE, Mont., March 24, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative medicine products and medical devices, is expanding its biologics ...
03/17/16 01:43 PMXtant Medical Holdings, Inc. :XTNT-US: Earnings Analysis: 2015 By the Numbers -
03/17/16 09:26 AMXtant Medical Holdings' (XTNT) CEO Dan Goldberger on Q4 2015 Results - Earnings Call Transcript - That transaction was closed on July 31, 2015. We changed the name of the combined company to Xtant Medical Holdings Inc. and moved up to the New York Stock Exchange under the XTNT ticker soon after that. Today, the company is led by myself as CEO ...
03/16/16 09:28 AMAuris Medical Holding AG (NASDAQ:EARS) Expected To Report Earnings On Monday - Perkins Capital Management Inc. acquired a new stake in Xtant Medical Holdings Inc (NASDAQ:XTNT) during the fourth quarter, according to its most recent 13F filing with the SEC. The shares closed up +0.11 points or 2.50% at $4.51 with 112,166.00 shares ...
03/16/16 09:28 AMXtant Medical Holdings Inc - Brean Capital restated a "buy" rating and set a $10.00 price objective on shares of Xtant Medical Holdings in a research note on Thursday, January 14th. 02 and a 12-month excessive of $7.96. Auris Medical Holding AG (EARS) announced that it will release ...
03/15/16 03:32 PMXtant™ Medical Reports Record $22.3 Million Revenue and 14.1% Growth for the Fourth Quarter 2015 - [GlobeNewswire] - See footnote about the use of pro forma financial information. Consolidated total revenue increased 14.1% to a record $22.3 million compared to pro forma fourth quarter 2014 revenue of $19.5 million Consolidated ...
03/15/16 06:07 AMQ4 2015 Xtant Medical Holdings Inc Earnings Release - After Market Close -
03/08/16 06:30 AMXtant Medical Holdings, Inc. to Report Fourth Quarter 2015 Financial Results on March 15, 2016 - [GlobeNewswire] - BELGRADE, Mont., March 08, 2016-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results ...
03/03/16 06:30 AMXtant™ Medical Receives CE Mark for Its Aranax™ Cervical Plating System and Irix-A™ Stand Alone Anterior Lumbar Interbody Fusion Device - [GlobeNewswire] - BELGRADE, Mont., March 03, 2016-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced CE clearance for its products Aranax™ ...
02/16/16 06:30 AMXtant™ Medical to Present at the Canaccord Genuity 2016 Musculoskeletal Conference - [GlobeNewswire] - BELGRADE, Mont., Feb. 16, 2016-- Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative medicine products and medical devices, ...
02/05/16 08:01 AMXtant Medical Holdings, Inc. - Xtant Medical Holdings, Inc. develops, manufactures, and markets biologics products in the United States and internationally. The company offers products for use in various applications, including enhancing fusion in spine surgery, relief of back pain with ...
02/05/16 08:01 AMXtant Medical Holdings, Inc. (BONE) - Medical Equipment - Deals and Alliances Profile - New Market Report - 05.02.2016 12:47:00 - Recently published research from GlobalData, "Xtant Medical Holdings, Inc. (BONE) - Medical Equipment - Deals and Alliances Profile", is now available at Fast Market Research (live-PR.com) - Xtant Medical Holdings, Inc. (Xtant Medical ...
01/22/16 04:28 PMXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers -
01/12/16 07:01 AM8:01 am Xtant Medical sees Q4 revs $22-22.2 mln vs $23.6 mln Capital IQ Consensus; gross margin 66.5-68% -
01/12/16 07:00 AMXtant Medical Holdings, Inc. Reports Preliminary Fourth Quarter 2015 Financial Results - [GlobeNewswire] - BELGRADE, Mont., Jan. 12, 2016-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced preliminary results of its fourth quarter ...
12/15/15 10:18 AMXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
12/15/15 10:01 AMXtant™ Medical Announces First Surgical Procedure With the Aranax™ Cervical Plating System - [GlobeNewswire] - BELGRADE, Mont., Dec. 15, 2015-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced the first surgical procedure of the previously ...
12/14/15 01:26 PMXtant Medical Holdings, Inc. Earnings Analysis: Q3, 2015 By the Numbers -
12/09/15 12:54 PMXtant™ Medical Announces First Surgical Case of Atrix-C™ Cervical Allograft Interbody Spacer - [GlobeNewswire] - BELGRADE, Mont., Dec. 09, 2015-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced the first surgical case of the Atrix-C ...
12/08/15 12:18 PMXTANT MEDICAL HOLDINGS, INC. Financials -
12/08/15 06:30 AMXtant™ Medical Announces the Global Launch for the Certex® OCT Spinal Fixation System - [GlobeNewswire] - BELGRADE, Mont., Dec. 08, 2015-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine ...
12/03/15 06:30 AMXtant™ Medical To Present at ICV Manhattan Conference - [GlobeNewswire] - BELGRADE, Mont., Dec. 03, 2015-- Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative medicine products and medical devices, ...
12/02/15 06:30 AMXtant™ Medical and Montana State University Develop Custom 3D Printer for Prototyping Reconstructive Implants - [GlobeNewswire] - BELGRADE, Mont., Dec. 02, 2015-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, Bacterin ...

Social

About Xtant Medical Holdings

Xtant Medical Holdings logoXtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: XTNT
  • CUSIP:
Key Metrics:
  • Previous Close: $1.79
  • 50 Day Moving Average: $1.99
  • 200 Day Moving Average: $2.34
  • P/E Ratio: N/A
  • P/E Growth: -0.06
  • Market Cap: $21.72M
  • Current Year EPS Consensus Estimate: $-1.40 EPS
  • Next Year EPS Consensus Estimate: $-0.67 EPS
Additional Links:
Xtant Medical Holdings (NASDAQ:XTNT) Chart for Sunday, July, 24, 2016